Health
Results: 1585-1596 of 8138

Augurex Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025

Implantica announces U.S. FDA has provided feedback on the final RefluxStop® PMA submission, Module 3

Synendos Therapeutics Reports Positive and Highly Promising Topline Results from Phase 1 Trials, Paving the Way for Phase 2 in Mental Health







